Skip to content
‹ Back to IndustriesSciences

For Wider Adoption of Small Modular Nuclear Reactors, Experts Call on Licensing & Permitting Reform

The future of scalable clean energy production is also the new dawn of nuclear with the advent of small modular nuclear reactors (SMRs), a promising technology capable of revolutionizing America’s and the world’s energy landscape. As the global push for greener energy sources intensifies, these reactors present a viable pathway towards achieving significant climate…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Nick Loris · · C3 SolutionsColoradoNick LorisNuclear Energy
Share

Key takeaways

01

The future of scalable clean energy production is also the new dawn of nuclear with the advent of small modular nuclear reactors (SMRs), a promising technology capable of revolutionizing America’s and the world’s energy landscape.

02

As the global push for greener energy sources intensifies, these reactors present a viable pathway towards achieving significant climate…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The future of scalable clean energy production is also the new dawn of nuclear with the advent of small modular nuclear reactors (SMRs), a promising technology capable of revolutionizing America’s and the world’s energy landscape. As the global push for greener energy sources intensifies, these reactors present a viable pathway towards achieving significant climate and environmental goals. As more U.S. states invest research and resources into studying the potential benefits of mass nuclear energy deployment, what does the industry need to do to speed up the adoption process?

The global decarbonization drive is fueling a resurgence in nuclear energy, with Colorado now potentially following suit thanks to the newly passed “Assess Advanced Energy Solutions In Rural Colorado” bill. Despite facing opposition over safety, cost, and environmental issues, Colorado is taking its queues from clean energy experts, who say nuclear power is necessary for true carbon-free power generation, as it can provide large-scale, low-carbon electricity continuously. Meanwhile, the U.S. Department of Energy, under the Biden administration, is promoting advanced nuclear reactor projects, though cost and technological hurdles remain. Reflecting shifting attitudes towards nuclear power, California has reversed the scheduled shutdown of the Diablo Canyon nuclear power plant in response to power shortages.

Nick Loris, Vice President of Public Policy at C3 Solutions, delves deeper into the transformative potential of small modular reactors and the critical policy reforms needed for their wider adoption in the U.S.

Nick’s Thoughts

“Small modular nuclear reactors have tremendous potential to meet America and the world’s energy needs while also meeting key environmental and climate objectives. They also have tremendous potential to meet America and the world’s energy security needs by weaning Europe off Russian natural gas. And we’ve seen American companies already committing to building SMRs in Europe. What we need is more of that action here in the United States and the collaboration between the national laboratories and the private sector is exactly what you want to see to help get a number of these technologies off the ground and to de-risk them. There’s a lot of excitement from venture capitalists to entrepreneurs and innovators, as well as the general public for nuclear power as support for the technology is the highest it’s been in 10 years.

What we really need to see now though is licensing and permitting reform. For instance, the Nuclear Regulatory Commission’s just licensed and certified NuScale’s reactor design, but it took half a billion dollars in costs for the company to get through the process, not to mention they started that process in 2008. So if we want to have more of these innovative technologies reach the marketplace to provide durable emissions-free power, we need more efficient regulatory and permitting processes while still maintaining the necessary environmental safeguards to get these technologies off the ground.”

Article written by Daniel Litwin.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Nick Loris
Nick LorisVice President of Public Policy

You can write about your years of experience, industry, or skills. (Feel free to copy and paste your LinkedIn 'About' info here).

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

UCB commits to Veeva Vault CRM for unified engagement

UCB commits to Veeva Vault CRM for unified engagement

UCB has committed to Veeva Vault CRM, which Veeva’s release presents as an agentic CRM platform to drive unified engagement worldwide. UCB and Veeva executives describe it as a stable foundation for UCB’s commercial strategy, while the AI claims, including the Agentic Call Report, come from Veeva’s product description. No go-live date or financial terms were given.

  • 01The executive statements focus on Vault CRM as a foundation. The AI pitch, including the Agentic Call Report, comes from Veeva’s product description.
  • 02Veeva says the Agentic Call Report turns field call records into "Commercial Evidence" about treatment barriers that went unseen before. If that works, call-report data becomes something UCB can analyze.
  • 03Neither company disclosed a go-live date or financial terms. The first rollout milestone UCB names will be the signal that the move is actually happening.

Nov 7, 2026

Why ISPE put peptide and oligo facility design in one guide

Why ISPE put peptide and oligo facility design in one guide

ISPE's new Baseline Guide covers oligonucleotide and peptide facility design in one document, says Jim Love of CRB. It pairs a GMP survey of existing plants with a sustainability outlook and a piping safety framework for scale-up, while FDA's oligonucleotide guidances under dockets opened in 2022 and 2024 remain the regulator's own reference.

  • 01Peptide plants inherited API chemistry thinking and oligo plants biotech thinking; ISPE’s guide puts both modalities in one facility document with both inheritances.
  • 02The guide has three parts: a GMP survey of existing oligo and peptide plants, a forecast of how sustainability and scale will change the processes, and a safety framework for connective piping and equipment.
  • 03FDA keeps its own oligonucleotide-specific guidances under dockets opened in 2022 and 2024, so the ISPE guide works as an industry consensus alongside regulation rather than in place of it.

Nov 5, 2026

Collagen builder Astrion outdrew AstraGin at NuLiv's Bangkok booth

Collagen builder Astrion outdrew AstraGin at NuLiv's Bangkok booth

NuLiv Science says Astrion, its collagen-building ingredient, drew more interest than AstraGin at Vitafoods Asia 2026 in Bangkok, held September 2 to 4. Brands also asked for probiotic strains for pet weight loss, children, and women's health. New trials for AstraGin in Nutrients and Senactiv provide updated evidence for these distinct ingredients.

  • 01At Vitafoods Asia 2026 in Bangkok, Astrion drew more booth interest than AstraGin, NuLiv’s absorption flagship.
  • 02NuLiv says probiotic requests are now split by pet, child and life stage, and the show preview lists strains for women’s health, emotional wellbeing and the gut-muscle axis.
  • 03A newly published crossover trial in Nutrients found AstraGin raised branched-chain amino acid absorption and grip strength in adults aged 60 to 80.

Nov 5, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Nick Loris
Nick Loris

Vice President of Public Policy

You can write about your years of experience, industry, or skills. (Feel free to copy and paste your LinkedIn 'About' info here).

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512